Taysha Gene Therapies Inc. (TSHA)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 70
+0.01
+0.1757%
$
1.82B Market Cap
- P/E Ratio
- Div Yield
1.76M Volume
-0.41 Eps
$ 5.69
Previous Close 
Want to track TSHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taysha Gene Therapies Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Zachary Canonico DIADEMA PARTNERS LP | 522,619 | $3.56M | $3.11M | -$449,451.97 | -12.63% |
 Mark Schafer Police & Firemen's Retirement System of New Jersey | 70,719 | $208,877.46 | $414,413.34 | $205,535.88 | 98.4% |
| BGI B Group Inc. B Group Inc. | 1.8M | $3.33M | $10.71M | $7.38M | 221.48% |
| CW Chung Wu Chung Wu Investment Group LLC | 2,000 | $11,000 | $11,720 | $720 | 6.55% |
| BM Berkeley Meredith Hughes Financial Services LLC | 6 | $41 | $35.16 | -$5.84 | -14.24% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 133,411 | $908,529 | $875,176.16 | -$33,352.84 | -3.67% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 5,797 | $12,705.07 | $38,028.32 | $25,323.25 | 199.32% |
